Highlighter is on. Drag to highlight text. Click a highlight to remove it.
ALL / Nephrology

Lower urinary tract symptoms in men

Lower urinary tract symptoms in men

Lower urinary tract symptoms (LUTS) in men are very common and are present in the majority of men aged > 50 years. They are most commonly secondary to benign prostatic hyperplasia but other causes should be considered including prostate cancer.

It is useful to classify the symptoms into 3 broad groups.

VoidingStoragePost-micturition
Hesitancy
Poor or intermittent stream
Straining
Incomplete emptying
Terminal dribbling
Urgency
Frequency
Nocturia
Urinary incontinence
Post-micturition dribbling
Sensation of incomplete emptying


Examination
  • urinalysis: exclude infection, check for haematuria
  • digital rectal examination: size and consistency of prostate
  • a PSA test may be indicated, but the patient should be properly counselled first

It is useful to get the patient to complete the following to guide management:
  • urinary frequency-volume chart: distinguish between urinary frequency, polyuria, nocturia, and nocturnal polyuria.
  • International Prostate Symptom Score (IPSS): assess the impact on the patient's life. This classifies the symptoms as mild, moderate or severe

Management

Predominately voiding symptoms
  • conservative measures include: pelvic floor muscle training, bladder training, prudent fluid intake and containment products
  • if 'moderate' or 'severe' symptoms offer an alpha-blocker
  • if the prostate is enlarged and the patient is 'considered at high risk of progression' then a 5-alpha reductase inhibitor should be offered
  • if the patient has an enlarged prostate and 'moderate' or 'severe' symptoms offer both an alpha-blocker and 5-alpha reductase inhibitor
  • if there are mixed symptoms of voiding and storage not responding to an alpha blocker then a antimuscarinic (anticholinergic) drug may be added

Predominately overactive bladder
  • conservative measures include moderating fluid intake
  • bladder retraining should be offered
  • antimuscarinic drugs should be offered if symptoms persist. NICE recommend oxybutynin (immediate release), tolterodine (immediate release), or darifenacin (once daily preparation)
  • mirabegron may be considered if first-line drugs fail

Nocturia
  • advise about moderating fluid intake at night
  • furosemide 40mg in late afternoon may be considered
  • desmopressin may also be helpful
+PassMedicine Notes

Lower urinary tract symptoms (LUTS) in men are very common and are present in the majority of men aged > 50 years. They are most commonly secondary to benign prostatic hyperplasia but other causes should be considered including prostate cancer.

It is useful to classify the symptoms into 3 broad groups.

Voiding _ Storage _ Post-micturition| Hesitancy Poor or intermittent stream Straining Incomplete emptying Terminal dribbling _ Urgency Frequency Nocturia Urinary incontinence _ Post-micturition dribbling Sensation of incomplete emptying| Examination
  • urinalysis: exclude infection, check for haematuria
  • digital rectal examination: size and consistency of prostate
  • a PSA test may be indicated, but the patient should be properly counselled first
It is useful to get the patient to complete the following to guide management:
  • urinary frequency-volume chart: distinguish between urinary frequency, polyuria, nocturia, and nocturnal polyuria.
  • International Prostate Symptom Score (IPSS): assess the impact on the patient's life. This classifies the symptoms as mild, moderate or severe

Management

Predominately voiding symptoms
  • conservative measures include: pelvic floor muscle training, bladder training, prudent fluid intake and containment products
  • if 'moderate' or 'severe' symptoms offer an alpha-blocker
  • if the prostate is enlarged and the patient is 'considered at high risk of progression' then a 5-alpha reductase inhibitor should be offered
  • if the patient has an enlarged prostate and 'moderate' or 'severe' symptoms offer both an alpha-blocker and 5-alpha reductase inhibitor
  • if there are mixed symptoms of voiding and storage not responding to an alpha blocker then a antimuscarinic (anticholinergic) drug may be added
Predominately overactive bladder
  • conservative measures include moderating fluid intake
  • bladder retraining should be offered
  • antimuscarinic drugs should be offered if symptoms persist. NICE recommend oxybutynin (immediate release), tolterodine (immediate release), or darifenacin (once daily preparation)
  • mirabegron may be considered if first-line drugs fail
Nocturia
  • advise about moderating fluid intake at night
  • furosemide 40mg in late afternoon may be considered
  • desmopressin may also be helpful


Saved ✓

MEDIA